Clinical trial · Interventional
Reducing Urban Cervical Cancer Disparities
Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance
NCT06416150CI-TRIAL-00081955recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Papilloma Viral Infection | — | UNRESOLVED | — |
Interventions
Interventions (9)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Stage 1 HERS | Behavioral | — | UNRESOLVED |
| Stage 1 SOC | Behavioral | — | UNRESOLVED |
| Stage 2 HERS | Behavioral | — | UNRESOLVED |
| Stage 2 HERS+HC | Behavioral | — | UNRESOLVED |
| Stage 3 HERS | Behavioral | — | UNRESOLVED |
| Stage 3 HERS+HC | Behavioral | — | UNRESOLVED |
| Stage 3 SOC | Behavioral | — | UNRESOLVED |
| Stage 4 HERS | Behavioral | — | UNRESOLVED |
| Stage 4 HERS+HC | Behavioral | — |
Design
Arms and outcomes
Arms (13)
- type
- EXPERIMENTAL
- label
- Stage 1 and 3 SoC
- description
- Start with Stage 1 Standard of Care; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 Standard of Care; patient attends 12-month follow-up appointment, no Stage 4 intervention.
- interventionNames
- Behavioral: Stage 1 SOC
- Behavioral: Stage 3 SOC
- type
- EXPERIMENTAL
- label
- Stage 1 and 3 SoC + Stage 4 HERS
- description
- Start with Stage 1 Standard of Care; patient attends baseline colposcopy appointment, no Stage 2 intervention. Continue with Stage 3 Standard of Care; patient does not attend 12-month follow-up appointment, continue with Stage 4 HERS intervention.
- interventionNames
- Behavioral: Stage 1 SOC
- Behavioral: Stage 3 SOC
- Behavioral: Stage 4 HERS
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites), * referral for colposcopic evaluation at the clinic sites, * able to communicate with ease in English, * have a cell phone with texting ability, and * competent to give consent. Exclusion Criteria: * are pregnant at the time of recruitment, * display current evidence or have a history of positive invasive carcinoma of the cervix, or * require follow-up but not a colposcopy.
References
Publications (0)
Data not yet available
No reference posted for this study.